Global clinical dementia rating of 0.5 in MCI masks variability related to level of function

Neurology

Volumn 76, Issue 7, 2011, Pages 652-659

  Chang, Y L ^a,c   Bondi, M W ^a,b   McEvoy, L K ^a   Fennema Notestine, C ^a   Salmon, D P ^a   Galasko, D ^a,b   Hagler, D J ^a   Dale, A M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN FUNCTION; BRAIN REGION; CLINICAL DEMENTIA RATING; COGNITION; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DISEASE COURSE; EPISODIC MEMORY; FEMALE; FRONTAL LOBE; GRAY MATTER; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MORPHOMETRICS; OUTCOME ASSESSMENT; PARIETAL LOBE; PRIORITY JOURNAL; RATING SCALE; SCORING SYSTEM; TASK PERFORMANCE; TEMPORAL LOBE;

EID: 79951591743     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31820ce6a5     Document Type: Article

References (40)

1. Petersen RC, Doody R, Kurz A, et al. Current concepts in mild cognitive impairment. Arch Neurol 2001;58:1985-1992. (Pubitemid 33143977)
2. Tabert MH, Albert SM, Borukhova-Milov L, et al. Functional deficits in patients with mild cognitive impairment: prediction of AD. Neurology 2002;58:758-764. (Pubitemid 34211555)
3. Peres K, Chrysostome V, Fabrigoule C, Orgogozo JM, Dartigues JF, Barberger-Gateau P. Restriction in complex activities of daily living in MCI: impact on outcome. Neurology 2006;67:461-466. (Pubitemid 44214971)
4. Bangen KJ, Jak AJ, Schiehser DM, et al. Complex activities of daily living vary by mild cognitive impairment subtype. J Int Neuropsychol Soc 2010;16:630-639.
5. Pereira FS, Yassuda MS, Oliveira AM, et al. Profiles of functional deficits in mild cognitive impairment and dementia: benefits from objective measurement. J Int Neuro-psychol Soc 2010;16:297-305.
6. Winblad B, Palmer K, Kivipelto M, et al. Mild cognitive impairment-beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 2004;256:240-246. (Pubitemid 39222993)
7. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry 1982;140:566-572. (Pubitemid 12124384)
8. Weintraub S, Salmon D, Mercaldo N, et al. The Alzheimer's Disease Centers' Uniform Data Set (UDS): the neu-ropsychologic test battery. Alzheimer Dis Assoc Disord 2009;23:91-101.
9. Petersen RC, Aisen PS, Beckett LA, et al. Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization. Neurology 2010;74:201-209.
10. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12: 189-198.
11. Kaplan E, Goodglass H, Weintraub S. The Boston Naming Test. Philadelphia: Lippincott Williams & Wilkins; 2001.
12. Rey A. l'Examen psychologique dans les cas d'encephalopathie traumatique. Arch Psychol 1941;28:286-340.
13. Wechsler D. Wechsler Memory Scale-Revised. San Antonio, TX: Psychological Corporation; 1987.
14. Reitan RM, Wolfson D. The Halstead Reitan Neuropsy-chological Test Battery: Theory and Clinical Interpretation, 2nd ed. Tempe, AZ: Neuropsychology Press; 1993.
15. Jovicich J, Czanner S, Greve D, et al. Reliability in multi-site structural MRI studies: effects of gradient non-linearity correction on phantom and human data. Neuroimage 2006;30:436-443.
16. Sled JG, Zijdenbos AP, Evans AC. A nonparametric method for automatic correction of intensity nonuni-formity in MRI data. IEEE Trans Med Imaging 1998; 17:87-97. (Pubitemid 128742012)
17. Fischl B, Salat DH, Busa E, et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 2002;33:341-355. (Pubitemid 34162530)
18. Fischl B, Dale AM. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci USA 2000;97:11050-11055.
19. Fischl B, Sereno MI, Dale AM. Cortical surface-based analysis: II: inflation, flattening, and a surface-based coordinate system. Neuroimage 1999;9:195-207. (Pubitemid 29369875)
20. Fischl B, Sereno MI, Tootell RB, Dale AM. High-resolution intersubject averaging and a coordinate system for the cortical surface. Hum Brain Mapp 1999;8:272-284.
21. Desikan RS, Segonne F, Fischl B, et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 2006;31:968-980. (Pubitemid 44183792)
22. Dale AM, Fischl B, Sereno MI. Cortical surface-based analysis: I: segmentation and surface reconstruction. Neu-roimage 1999;9:179-194. (Pubitemid 29369874)
23. Fennema-Notestine C, Hagler DJ Jr, McEvoy LK, et al. Structural MRI biomarkers for preclinical and mild Alzheimer's disease. Hum Brain Mapp 2009;30:3238-3253.
24. Lumley T, Diehr P, Emerson S, Chen L. The importance of the normality assumption in large public health data sets. Annu Rev Public Health 2002;23:151-169. (Pubitemid 34508071)
25. Buckner RL, Head D, Parker J, et al. A unified approach for morphometric and functional data analysis in young, old, and demented adults using automated atlas-based head size normalization: reliability and validation against manual measurement of total intracranial volume. Neuroimage 2004;23:724-738. (Pubitemid 39370623)
26. Zalla T, Phipps M, Grafman J. Story processing in patients with damage to the prefrontal cortex. Cortex 2002;38: 215-231. (Pubitemid 34594141)
27. Chang YL, Jacobson MW, Fennema-Notestine C, et al. Level of executive function influences verbal memory in amnestic mild cognitive impairment and predicts prefron-tal and posterior cingulate thickness. Cereb Cortex 2010; 20:1305-1313.
28. Cato MA, Delis DC, Abildskov TJ, Bigler E. Assessing the elusive cognitive deficits associated with ventromedial pre-frontal damage: a case of a modern-day Phineas Gage. J Int Neuropsychol Soc 2004;10:453-465. (Pubitemid 38779816)
29. Whitwell JL, Przybelski SA, Weigand SD, et al. 3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease. Brain 2007;130:1777-1786. (Pubitemid 47343806)
30. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991;82: 239-259.
31. Petersen RC, Roberts RO, Knopman DS, et al. Mild cognitive impairment: ten years later. Arch Neurol 2009;66: 1447-1455.
32. Saxton J, Snitz BE, Lopez OL, et al. Functional and cognitive criteria produce different rates of mild cognitive impairment and conversion to dementia. J Neurol Neurosurg Psychiatry 2009;80:737-743.
33. Jak AJ, Urban S, McCauley A, et al. Profile of hippocam-pal volumes and stroke risk varies by neuropsychological definition of mild cognitive impairment. J Int Neuropsy-chol Soc 2009;15:890-897.
34. Loewenstein DA, Acevedo A, Small BJ, Agron J, Crocco E, Duara R. Stability of different subtypes of mild cognitive impairment among the elderly over a 2- to 3-year follow-up period. Dement Geriatr Cogn Disord 2009;27: 418-423.
35. Chang YL, Bondi MW, Fennema-Notestine C, et al. Brain substrates of learning and retention in mild cognitive impairment diagnosis and progression to Alzheimer's disease. Neuropsychologia 2010;48:1237-1247.
36. Daly E, Zaitchik D, Copeland M, Schmahmann J, Gunther J, Albert M. Predicting conversion to Alzheimer disease using standardized clinical information. Arch Neurol 2000;57:675-680. (Pubitemid 30252802)
37. Gelb DJ. Measurement of progression in Alzheimer's disease: a clinician's perspective. Stat Med 2000;19:1393-1400. (Pubitemid 30346232)
38. Gelb DJ, St Laurent RT. Alternative calculation of the global clinical dementia rating. Alzheimer Dis Assoc Disord 1993;7:202-211. (Pubitemid 23351191)
39. O'Bryant SE, Waring SC, Cullum CM, et al. Staging dementia using Clinical Dementia Rating Scale Sum of Boxes scores: a Texas Alzheimer's research consortium study. Arch Neurol 2008;65:1091-1095.
40. Grundman M, Petersen RC, Ferris SH, et al. Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol 2004; 61:59-66. (Pubitemid 38067415)